Buy Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders [An article from: Clinical Psychology Review] by M.T. Smith, M.I. Huang, R. Manber available and for sale on Brightsurf

View Larger Image	Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders [An article from: Clinical Psychology Review] by M.T. Smith, M.I. Huang, R. Manber List Price:  $7.95 Available:  Available for download now Studio:  Elsevier Binding:  Digital Publication Date:  July 01, 2005 Publisher:  Elsevier
FORMATS HTML EDITORIAL REVIEWS Product Description This digital document is a journal article from Clinical Psychology Review, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: Insomnia is a pervasive problem for many patients suffering from medical and psychiatric conditions. Even when the comorbid disorders are successfully treated, insomnia often fails to remit. In addition to compromising quality of life, untreated insomnia may also aggravate and complicate recovery from the comorbid disease. Cognitive behavior therapy for insomnia (CBT-I) has an established efficacy for primary insomnia, but less is known about its efficacy for insomnia occurring in the context of medical and psychiatric conditions. The purpose of this article is to present a rationale for using CBT-I in medical and psychiatric disorders, review the extant outcome literature, highlight considerations for adapting CBT-I procedures in specific populations, and suggest directions for future research. Outcome studies were identified for CBT-I in mixed medical and psychiatric conditions, cancer, chronic pain, HIV, depression, posttraumatic stress disorder, and alcoholism. Other disorders discussed include: bipolar disorder, eating disorders, generalized anxiety, and obsessive compulsive disorder. The available data demonstrate moderate to large treatment effects (Cohen's d, range=0.35-2.2) and indicate that CBT-I is a promising treatment for individuals with medical and psychiatric comorbidity. Although the literature reviewed here is limited by a paucity of randomized, controlled studies, the available data suggest that by improving sleep, CBT-I might also indirectly improve medical and psychological endpoints. This review underscores the need for future research to test the efficacy of adaptations of CBT-I to disease specific conditions and symptoms.